- Home
- ABSI vs HRTX Comparison
ABSI vs HRTX Comparison
Compare ABSI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- HRTX
- Stock Information
- Founded
- ABSI 2011
- HRTX 1983
- Country
- ABSI United States
- HRTX United States
- Employees
- ABSI N/A
- HRTX N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ABSI Health Care
- HRTX Health Care
- Exchange
- ABSI Nasdaq
- HRTX Nasdaq
- Market Cap
- ABSI 338.0M
- HRTX 276.1M
- IPO Year
- ABSI 2021
- HRTX 1987
- Fundamental
- Price
- ABSI $2.63
- HRTX $1.40
- Analyst Decision
- ABSI Strong Buy
- HRTX Strong Buy
- Analyst Count
- ABSI 5
- HRTX 2
- Target Price
- ABSI $7.98
- HRTX $4.50
- AVG Volume (30 Days)
- ABSI 5.6M
- HRTX 2.5M
- Earning Date
- ABSI 08-12-2025
- HRTX 08-08-2025
- Dividend Yield
- ABSI N/A
- HRTX N/A
- EPS Growth
- ABSI N/A
- HRTX N/A
- EPS
- ABSI N/A
- HRTX N/A
- Revenue
- ABSI $4,138,000.00
- HRTX $149,694,000.00
- Revenue This Year
- ABSI $74.53
- HRTX $12.08
- Revenue Next Year
- ABSI $296.01
- HRTX $12.57
- P/E Ratio
- ABSI N/A
- HRTX N/A
- Revenue Growth
- ABSI 27.32
- HRTX 9.78
- 52 Week Low
- ABSI $2.01
- HRTX $1.04
- 52 Week High
- ABSI $6.33
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- ABSI 40.89
- HRTX 37.01
- Support Level
- ABSI $2.49
- HRTX $1.25
- Resistance Level
- ABSI $3.40
- HRTX $1.47
- Average True Range (ATR)
- ABSI 0.19
- HRTX 0.10
- MACD
- ABSI -0.05
- HRTX -0.00
- Stochastic Oscillator
- ABSI 15.38
- HRTX 30.43
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.